LUPPI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.765
EU - Europa 7.111
AS - Asia 3.854
SA - Sud America 563
AF - Africa 71
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 20.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.596
IT - Italia 3.898
SG - Singapore 1.310
GB - Regno Unito 1.234
CN - Cina 901
VN - Vietnam 434
BR - Brasile 421
SE - Svezia 410
HK - Hong Kong 378
DE - Germania 311
FR - Francia 283
FI - Finlandia 217
UA - Ucraina 193
RU - Federazione Russa 187
BD - Bangladesh 185
TR - Turchia 123
NL - Olanda 117
IN - India 112
CA - Canada 95
KR - Corea 84
BG - Bulgaria 63
ID - Indonesia 63
AR - Argentina 51
MX - Messico 48
IQ - Iraq 43
JP - Giappone 43
IE - Irlanda 33
BE - Belgio 31
ZA - Sudafrica 23
PL - Polonia 22
ES - Italia 21
EC - Ecuador 20
PK - Pakistan 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 16
IR - Iran 15
SA - Arabia Saudita 14
CL - Cile 13
CO - Colombia 12
LT - Lituania 12
MY - Malesia 12
NP - Nepal 12
CH - Svizzera 11
MA - Marocco 11
AU - Australia 10
PY - Paraguay 10
TW - Taiwan 10
AT - Austria 9
TH - Thailandia 9
TN - Tunisia 9
JO - Giordania 8
KE - Kenya 8
PH - Filippine 8
AZ - Azerbaigian 7
HR - Croazia 7
LV - Lettonia 7
PE - Perù 7
EU - Europa 6
IL - Israele 6
LB - Libano 6
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
UZ - Uzbekistan 4
BZ - Belize 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
PR - Porto Rico 3
SI - Slovenia 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AL - Albania 1
BB - Barbados 1
Totale 20.363
Salva come PNG Salva come JPEG
Città #
Ashburn 890
Southend 887
Singapore 865
Fairfield 792
Santa Clara 758
Chandler 478
Woodbridge 476
Houston 397
San Jose 373
Hong Kong 368
Ann Arbor 308
Milan 278
Rome 278
Seattle 274
Wilmington 265
Jacksonville 250
Cambridge 244
Dearborn 233
Nyköping 222
Beijing 201
London 163
Helsinki 162
Council Bluffs 158
New York 157
Hefei 155
Modena 155
Los Angeles 132
Ho Chi Minh City 121
Hanoi 111
Chicago 104
San Diego 100
The Dalles 94
Florence 72
Naples 69
Seoul 67
Dallas 66
Shanghai 64
Sofia 60
Bologna 58
Princeton 56
Izmir 55
Palermo 53
Eugene 52
Buffalo 51
Catania 48
Jakarta 47
Lauterbourg 47
Salt Lake City 45
São Paulo 45
Bari 43
Moscow 43
Orem 43
Redwood City 40
Munich 39
Columbus 36
Bremen 33
Genoa 32
Phoenix 31
Turin 31
Verona 31
Tokyo 29
Brussels 28
Boardman 27
Chennai 27
Frankfurt am Main 27
Montreal 27
Cagliari 25
Padova 25
Toronto 25
Da Nang 22
Atlanta 21
Mexico City 21
Baghdad 20
Salerno 20
Guangzhou 19
Mountain View 19
Falls Church 18
Haiphong 18
Bergamo 17
Pisa 17
Tampa 17
Boston 16
Brescia 16
Manchester 16
Parma 16
Brooklyn 15
Reggio Emilia 15
Treviso 15
Warsaw 15
Des Moines 14
Elk Grove Village 14
Fremont 14
Turku 14
Buenos Aires 13
Cinisello Balsamo 13
Miano 13
Mumbai 13
Denver 12
Dublin 12
Johannesburg 12
Totale 12.543
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.855
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 486
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 440
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 421
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 414
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 382
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 375
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 373
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 361
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 360
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 358
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 349
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 345
Treatment of chronic obstructive pulmonary disease and its comorbidities 332
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 332
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 330
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 329
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 320
Complex chronic co-morbidities of COPD 314
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 310
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 309
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 308
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 302
Clusterin (CLU) and lung cancer 301
Prognostic role of clusterin in resected adenocarcinomas of the lung. 301
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 297
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 294
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 288
Management of Idiopathic Pulmonary Fibrosis 285
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 285
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 284
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 282
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 282
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 270
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 263
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 254
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 251
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 250
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 244
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 240
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 238
Challenges in idiopathic interstitial lung disease 232
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 224
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 205
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 205
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 196
Therapeutic approaches to idiopathic pulmonary fibrosis 184
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 166
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 161
Medicina personalizzata e fibrosi polmonare idiopatica 160
Malattie infiltrative diffuse del polmone 151
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 151
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 139
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 117
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 116
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 104
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project 66
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 61
Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study 47
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 43
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus 12
Totale 20.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.444
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 0 122
2021/20221.458 86 116 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20253.315 198 112 115 263 593 432 282 211 338 136 270 365
2025/20265.714 345 191 395 599 902 443 771 254 557 519 406 332
Totale 20.546